DYK, Circuit Judge.
Appellants Fresenius USA, Inc. and Fresenius Medical Care Holdings, Inc. (collectively, "Fresenius") brought a declaratory judgment action against Baxter International, Inc., and Baxter Healthcare Corporation (collectively, "Baxter"), alleging, inter alia, that claims 26-31 of U.S. Patent No. 5,247,434 ("the '434 patent") were invalid and not infringed. Baxter counterclaimed for infringement. The district As you are aware we have offered this as a free subscription over the past years and we have now made it a paid service.Look forward to your continued patronage.NEVER MISS A DECISION. START YOUR SUBSCRIPTION.
Uncompromising quality. Enduring impact.
Your support ensures a bright future for independent legal reporting.GET STARTED
OR
Read it with your Leagle account.
Sign in to
continue